Scientists from Paul Scherrer Institute and University College London developed bioactive nanoparticles that cleared toxic proteins in mice, reversing Alzheimer’s symptoms and restoring cognition, offering a potential shift toward vascular repair-based therapies for neurodegenerative diseases
